Journal ArticleDOI
Seneffekter etter kreftbehandling
About:
This article is published in Sykepleien.The article was published on 2018-11-01. It has received 3 citations till now.read more
Citations
More filters
A prospective surveillance model for rehabilitation for women with breast cancer
Nicole L. Stout,Jill M. Binkley,Kathryn H. Schmitz,Kimberly S. Andrews,Sandra C. Hayes,Kristin L. Campbell,Margaret L. McNeely,Peter W. Soballe,Ann M. Berger,Andrea L. Cheville,Carol J. Fabian,Lynn H. Gerber,Susan R. Harris,Karin Johansson,Andrea L. Pusic,Robert G. Prosnitz,Robert A. Smith +16 more
TL;DR: A prospective surveillance model for physical rehabilitation and exercise that can be integrated with disease treatment to create a more comprehensive approach to survivorship health care is proposed.
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer
Raymond Javan Chan,Raymond Javan Chan,Alexandra L. McCarthy,Jackie Devenish,Karen A. Sullivan,Alexandre Chan +5 more
TL;DR: In this paper, a systematic review investigates the effectiveness of pharmacologic and non-pharmacologic interventions to manage cognitive alterations associated with breast cancer treatment, including cognitive training and physical activity interventions.
Journal ArticleDOI
Prevalence of late and long-term effects of cancer (treatment) and use of complementary and alternative medicine in Norway
Agnete Egilsdatter Kristoffersen,Barbara Wider,Jorunn V. Nilsen,Mona Bjelland,Dana C Mora,Johanna Hök Nordberg,Ann Ragnhild Broderstad,Kiwumulo Nakandi,Trine Stub +8 more
TL;DR: In this article , the authors used a modified cancer-specific version of the International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q) to determine the level of cancer patients suffering from late and long-term effects of cancer diagnosis and treatment in Norway.
References
More filters
Journal ArticleDOI
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
Neil K. Aaronson,Sam H Ahmedzai,Bengt Bergman,Monika Bullinger,Ann Cull,Nicole Duez,Antonio Filiberti,Henning Flechtner,Stewart B. Fleishman,Johanna C. J. M. de Haes,Stein Kaasa,M. Klee,David Osoba,Darius Razavi,Peter B. Rofe,Simon Schraub,Kommer C. A. Sneeuw,Marianne Sullivan,Fumikazu Takeda +18 more
TL;DR: The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
Journal ArticleDOI
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Salim Yusuf,Steven Hawken,Stephanie Ôunpuu,Tony Dans,Alvaro Avezum,Fernando Lanas,Matthew J. McQueen,Andrzej Budaj,Prem Pais,John Varigos,Liu Lisheng +10 more
TL;DR: Abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions.
Journal ArticleDOI
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
TL;DR: The IIEF addresses the relevant domains of male sexual function, is psychometrically sound, and has been linguistically validated in 10 languages and demonstrates the sensitivity and specificity for detecting treatment-related changes in patients with erectile dysfunction.
Journal ArticleDOI
Borg's Perceived Exertion and Pain Scales
TL;DR: Gunnar Borg's Perceived Exertion and Pain Scales : Medicine ...
Journal ArticleDOI
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B. Finnerup,Nadine Attal,Simon Haroutounian,Ewan D McNicol,Ralf Baron,Robert H. Dworkin,Ian Gilron,Maija Haanpää,Per Hansson,Per Hansson,Troels S. Jensen,Troels S. Jensen,Peter R. Kamerman,Karen Lund,Andrew Moore,Srinivasa N. Raja,Andrew S.C. Rice,Andrew S.C. Rice,Michael C. Rowbotham,Emily S. Sena,Emily S. Sena,Philip J. Siddall,Philip J. Siddall,Blair H. Smith,Mark S. Wallace +24 more
TL;DR: The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin.